JMP Securities reiterated their market outperform rating on shares of STERIS (NYSE:STE – Free Report) in a report published on Thursday,Benzinga reports. The firm currently has a $265.00 price target on the medical equipment provider’s stock.
A number of other research analysts also recently issued reports on STE. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Finally, Stephens reaffirmed an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.
Get Our Latest Stock Report on STE
STERIS Trading Up 1.9 %
STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, equities analysts forecast that STERIS will post 9.08 EPS for the current fiscal year.
STERIS Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio is presently 48.41%.
Hedge Funds Weigh In On STERIS
Institutional investors have recently bought and sold shares of the company. Avalon Trust Co purchased a new stake in shares of STERIS in the fourth quarter valued at about $30,000. Human Investing LLC acquired a new position in STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC raised its stake in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC boosted its stake in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Further Reading
- Five stocks we like better than STERIS
- Insider Trades May Not Tell You What You Think
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- What is the S&P 500 and How It is Distinct from Other Indexes
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.